norsalsolinol has been researched along with Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klingemann, I; Moser, A; Scholz, J | 1 |
| DeCuypere, M; Hao, R; Kalabokis, VN; LeDoux, MS; Miller, DD; Schroeder, D | 1 |
| Allievi, C; Della Vedova, F; Dordain, G; Dostert, P; Durif, F; La Croix, R; Strolin Benedetti, M; Vernay, D | 1 |
3 other study(ies) available for norsalsolinol and Parkinson Disease
| Article | Year |
|---|---|
Increased systemic levels of norsalsolinol derivatives are induced by levodopa treatment and do not represent biological markers of Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Biomarkers; Chromatography, High Pressure Liquid; Female; Humans; Inactivation, Metabolic; Isoquinolines; Levodopa; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Reference Values; Salsoline Alkaloids | 2004 |
Localization of N-methyl-norsalsolinol within rodent and human brain.
Topics: Animals; Brain; Brain Chemistry; Chromatography, High Pressure Liquid; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Parkinson Disease; Rats; Rats, Sprague-Dawley; Salsoline Alkaloids | 2008 |
Dopamine-derived tetrahydroisoquinolines and Parkinson's disease.
Topics: Aged; Aged, 80 and over; Female; Humans; Isoquinolines; Male; Middle Aged; Parkinson Disease; Reference Values; Salsoline Alkaloids | 1993 |